Timothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, Juzar Ali, Alan Barker, Ashwin Basavaraj, Megan Behrman, Amanda E Brunton, Sarah Chalmers, Radmila Choate, Nathan C Dean, Angela DiMango, David Fraulino, Margaret M Johnson, Nicole C Lapinel, Diego J Maselli, Pamela J McShane, Mark L Metersky, Bruce E Miller, Edward T Naureckas, Anne E O'Donnell, Kenneth N Olivier, Elly Prusinowski, Marcos I Restrepo, Christopher J Richards, Gloria Rhyne, Andreas Schmid, George M Solomon, Ruth Tal-Singer, Byron Thomashow, Gregory Tino, Kevin Tsui, Sumith Abraham Varghese, Heather E Warren, Kevin Winthrop, Beth Shoshanna Zha
RATIONALE: Nontuberculous mycobacteria (NTM) are prevalent among patients with bronchiectasis. However, the long-term natural history of patients with NTM and bronchiectasis is not well described. OBJECTIVE: To assess the impact of NTM on 5-year clinical outcomes and mortality in patients with bronchiectasis. METHODS: Patients in the United States Bronchiectasis and Nontuberculous Mycobacteria Research Registry with ≥5 years of follow-up were eligible...
April 26, 2024: American Journal of Respiratory and Critical Care Medicine